Teva, Baxter Hit With $500M Damages In Hepatitis Case

Law360, New York (May 7, 2010, 6:40 PM EDT) -- U.S. subsidiaries of Teva Pharmaceuticals Industries Ltd. and Baxter International Inc. reportedly have been hit with a $500 million punitive damages award in the first suit among hundreds to go to trial after an outbreak of hepatitis C in 2008 that plaintiffs say was spread because vials of an anesthetic were mislabeled.

A jury handed down the award Friday in the Clark County District Court in Las Vegas, ordering Teva Parenteral Medicines Inc. to fork over $356 million and Baxter Healthcare Services to pay $144 million,...
To view the full article, register now.